MSB 2.17% $1.13 mesoblast limited

Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-108

  1. 101 Posts.
    lightbulb Created with Sketch. 39
    Fingers crossed that this life-saving treatment gets approved this time.

    ...and if not, then it will probably feature in a Netflix documentary on corruption in another 5-10 years
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.